ELDN
Eledon Pharmaceuticals Inc
2.50$
+2.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +1.1% | +2.1% | -18.6% | +11.4% | – | – | – | – | – | – | – | |
| – | -1.4% | -0.9% | +80.8% | -41.8% | +269.2% | -56.5% | -5.9% | -9.9% | +1.5% | -10.7% | +43.2% | – | |
| – | – | – | +1,092.5% | +115.3% | -122.3% | – | – | -18.5% | +65.2% | -193.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -35.7% | +270.1% | – | +284.3% | -17.1% | -264.9% | – | +290.1% | – | |
| – | – | – | +4,807,000.0% | -89.0% | +1,417.5% | -99.9% | -100.0% | – | – | -100.0% | – | – | |
| – | – | +10.4% | +1,854.4% | -194.6% | – | -187.4% | – | – | – | -187.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.